Details about Simon Wakeman
Access statistics for papers by Simon Wakeman.
Last updated 2022-11-06. Update your information in the RePEc Author Service.
Short-id: pwa760
Jump to
Journal Articles
Working Papers
2015
- Measuring the innovative activity of New Zealand firms
Working Papers, New Zealand Productivity Commission
View citations (1)
- What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry
ESMT Research Working Papers, ESMT European School of Management and Technology
View citations (1)
See also Journal Article What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry, Research Policy, Elsevier (2016)
View citations (40) (2016)
2013
- Technology commercialization strategy in a dynamic context: Developing specialized complementary assets in entrepreneurial firms
ESMT Research Working Papers, ESMT European School of Management and Technology
View citations (1)
2012
- How does obtaining intellectual property rights impact technology commercialization strategy for start-up innovators? Reconciling the effects on licensing vs. financing
ESMT Research Working Papers, ESMT European School of Management and Technology
View citations (1)
2010
- Profiting from technological capabilities: Technology commercialization strategy in a dynamic context
ESMT Research Working Papers, ESMT European School of Management and Technology
View citations (2)
2008
- Technology Commercialization Strategy in a Dynamic Context: Complementary Assets, Hybrid Contracts, and Experiential Learing
DRUID Working Papers, DRUID, Copenhagen Business School, Department of Industrial Economics and Strategy/Aalborg University, Department of Business Studies
Journal Articles
2016
- What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry
Research Policy, 2016, 45, (5), 1091-1102
View citations (40)
See also Working Paper What do patent-based measures tell us about product commercialization? Evidence from the pharmaceutical industry, ESMT Research Working Papers (2015)
View citations (1) (2015)